These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 34840484)

  • 1. The Outcome in Cirrhosis after Hospital Discharge is Not Worsened with COVID-19 Infection: A Propensity Score-matched Analysis.
    Vaishnav M; Elhence A; Biswas S; Pathak P; Anand A; Sheikh S; Singh V; Maitra S; Goel A; Shalimar
    J Clin Exp Hepatol; 2022; 12(3):830-840. PubMed ID: 34840484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of in-hospital Outcomes in Patients With Cirrhosis and Coronavirus Disease-2019.
    Elhence A; Vaishnav M; Biswas S; Anand A; Gunjan D; Kedia S; Mahapatra SJ; Nayak B; Sheikh S; Soni KD; Trikha A; Goel A; Shalimar
    J Clin Exp Hepatol; 2022; 12(3):876-886. PubMed ID: 34728983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting Mortality Across a Broad Spectrum of Liver Disease-An Assessment of Model for End-Stage Liver Disease (MELD), Child-Turcotte-Pugh (CTP), and Creatinine-Modified CTP Scores.
    Chawla YK; Kashinath RC; Duseja A; Dhiman RK
    J Clin Exp Hepatol; 2011 Dec; 1(3):161-8. PubMed ID: 25755381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of COVID-19 on Pre-existing Liver disease: What Hepatologist Should Know?
    Sharma P; Kumar A; Anikhindi S; Bansal N; Singla V; Shivam K; Arora A
    J Clin Exp Hepatol; 2021; 11(4):484-493. PubMed ID: 33398223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical features and predictors of outcome in acute hepatitis A and hepatitis E virus hepatitis on cirrhosis.
    Radha Krishna Y; Saraswat VA; Das K; Himanshu G; Yachha SK; Aggarwal R; Choudhuri G
    Liver Int; 2009 Mar; 29(3):392-8. PubMed ID: 19267864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determinants of Outcomes in Autoimmune Hepatitis Presenting as Acute on Chronic Liver Failure Without Extrahepatic Organ Dysfunction upon Treatment With Steroids.
    Sharma S; Agarwal S; Gopi S; Anand A; Mohta S; Gunjan D; Yadav R; Saraya A
    J Clin Exp Hepatol; 2021; 11(2):171-180. PubMed ID: 33746441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural History of Cirrhosis of Liver after First Decompensation: A Prospective Study in India.
    Shah AS; Amarapurkar DN
    J Clin Exp Hepatol; 2018 Mar; 8(1):50-57. PubMed ID: 29743797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overview of Complications in Cirrhosis.
    Premkumar M; Anand AC
    J Clin Exp Hepatol; 2022; 12(4):1150-1174. PubMed ID: 35814522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The presence of hepatitis B core antibody is associated with more advanced liver disease in alcoholic patients with cirrhosis.
    Zhang M; Wu R; Jiang J; Minuk GY; Niu J
    Alcohol; 2013 Nov; 47(7):553-8. PubMed ID: 24041840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ABIDE: An Accurate Predictive Model of Liver Decompensation in Patients With Nonalcoholic Fatty Liver-Related Cirrhosis.
    Calzadilla-Bertot L; Vilar-Gomez E; Wong VW; Romero-Gomez M; Aller-de la Fuente R; Wong GL; Castellanos M; Eslam M; Desai AP; Jeffrey GP; George J; Chalasani N; Adams LA
    Hepatology; 2021 Jun; 73(6):2238-2250. PubMed ID: 32978796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of and Factors Associated With Minimal Hepatic Encephalopathy in Patients With Cirrhosis of Liver.
    Bale A; Pai CG; Shetty S; Balaraju G; Shetty A
    J Clin Exp Hepatol; 2018 Jun; 8(2):156-161. PubMed ID: 29892178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short-term mortality in patients with cirrhosis of the liver and acute kidney injury: A prospective observational study.
    Kumar U; Kumar R; Jha SK; Jha AK; Dayal VM; Kumar A
    Indian J Gastroenterol; 2020 Oct; 39(5):457-464. PubMed ID: 33175368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrated model for end-stage liver disease maybe superior to some other model for end-stage liver disease-based systems in addition to Child-Turcotte-Pugh and albumin-bilirubin scores in patients with hepatitis B virus-related liver cirrhosis and spontaneous bacterial peritonitis.
    Chen PC; Chen BH; Huang CH; Jeng WJ; Hsieh YC; Teng W; Chen YC; Ho YP; Sheen IS; Lin CY
    Eur J Gastroenterol Hepatol; 2019 Oct; 31(10):1256-1263. PubMed ID: 31498284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The model for the end-stage liver disease and Child-Pugh score in predicting prognosis in patients with liver cirrhosis and esophageal variceal bleeding.
    Benedeto-Stojanov D; Nagorni A; Bjelaković G; Stojanov D; Mladenović B; Djenić N
    Vojnosanit Pregl; 2009 Sep; 66(9):724-8. PubMed ID: 19877551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Study on the application value of MELD-Na, CLIF-C OFs, COSSH-ACLFs and NLR scoring systems in patients with hepatitis B virus related acute-on-chronic liver failure].
    Miao J; Guo L; Wang L; Cui H; Li Q; Wang J; Zhu B; Jia J
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Dec; 32(12):1496-1501. PubMed ID: 33541504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Hepatic and Extrahepatic Insults on the Outcome of Acute-on-Chronic Liver Failure.
    Gupta T; Dhiman RK; Rathi S; Agrawal S; Duseja A; Taneja S; Chawla Y
    J Clin Exp Hepatol; 2017 Mar; 7(1):9-15. PubMed ID: 28348465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Machine Learning-based Development and Validation of a Scoring System for Screening High-Risk Esophageal Varices.
    Dong TS; Kalani A; Aby ES; Le L; Luu K; Hauer M; Kamath R; Lindor KD; Tabibian JH
    Clin Gastroenterol Hepatol; 2019 Aug; 17(9):1894-1901.e1. PubMed ID: 30708109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical outcomes following DAA therapy in patients with HCV-related cirrhosis depend on disease severity.
    Krassenburg LAP; Maan R; Ramji A; Manns MP; Cornberg M; Wedemeyer H; de Knegt RJ; Hansen BE; Janssen HLA; de Man RA; Feld JJ; van der Meer AJ
    J Hepatol; 2021 May; 74(5):1053-1063. PubMed ID: 33242501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of clinical outcomes and impact of SVR in American and Chinese patients with chronic hepatitis C.
    Rao H; Liu H; Wu E; Yang M; Feng B; Lin A; Fei R; Fontana RJ; Wei L; Lok AS
    JHEP Rep; 2020 Aug; 2(4):100136. PubMed ID: 32715286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Baseline MELD score predicts hepatic decompensation during antiviral therapy in patients with chronic hepatitis C and advanced cirrhosis.
    Dultz G; Seelhof M; Herrmann E; Welker MW; Friedrich-Rust M; Teuber G; Kronenberger B; von Wagner M; Vermehren J; Sarrazin C; Zeuzem S; Hofmann WP
    PLoS One; 2013; 8(8):e71262. PubMed ID: 23936497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.